4D Molecular Therapeutics Inc (FDMT) earnings · rev $85.2M
These earnings events as JSON? API free 100/day4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
This FDMT earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported FDMT revenue for 2025-12-31 was $85.2M. Net income was -$140.1M. Revenue was up 230194.6% from 2024-12-31 to 2025-12-31. FDMT currently screens at market cap $518.1M.
When the next FDMT 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 230194.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full FDMT research stays on the stock page; the tape stays on the quote page.
FDMT earnings FAQ
What are FDMT's latest revenue and net income?
Latest cached 4D Molecular Therapeutics Inc (FDMT) revenue for Dec 31, 2025 was $85.2M. Net income was -$140.1M. Statements: https://lician.com/financials/fdmt
What is FDMT's latest diluted EPS?
Latest cached 4D Molecular Therapeutics Inc (FDMT) diluted EPS for Dec 31, 2025 was -$2.42.
What period does the latest FDMT earnings print cover?
The latest cached 4D Molecular Therapeutics Inc (FDMT) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did FDMT revenue change from the prior cached period?
Cached 4D Molecular Therapeutics Inc (FDMT) revenue was up 230194.6% from $37.0K (Dec 31, 2024) to $85.2M (Dec 31, 2025). Statements: https://lician.com/financials/fdmt
Where are FDMT earnings listed?
Cached earnings facts for 4D Molecular Therapeutics Inc (FDMT) are listed at https://lician.com/earnings/fdmt. Statements: https://lician.com/financials/fdmt
Not investment advice.